6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

Details for Australian Patent Application No. 2011202788 (hide)

Owner Eli Lilly and Company

Inventors Singh, Ajay; Lee, Wai-Man; Deo, Arundhati S.; Galka, Christopher Stanley; Siedem, Christopher Stephen; Zhang, Deyi; Victor, Frantz; Allen, John Gordon; Briner, Karin; Martinez-Grau, Maria Angeles; Reinhard, Matthew Robert; Rodriguez, Michael John; Cohen, Michael Philip; Mazanetz, Michael Philip; Tidwell, Michael Wade; Conway, Richard Gerard; Rothhaar, Roger Ryan; Hellman, Sarah Lynne; Boyd, Steven Armen; Williams, Andrew Caerwyn

Agent Spruson & Ferguson

Pub. Number AU-B-2011202788

Parent 2005217602

Filing date 10 June 2011

Wipo publication date 30 June 2011

Acceptance publication date 26 April 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

30 June 2011 Application Open to Public Inspection

  Published as AU-B-2011202788

30 June 2011 Complete Application Filed

3 November 2011 Section 223 Application Allowed

  Eli Lilly and Company The time in which to make a further application for a divisional patent has been extended to 17 Jun 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

26 April 2012 Application Accepted

  Published as AU-B-2011202788

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202789-Solar heat-utilizing water heater system

2011202787-Method and composition for transdermal drug delivery